OXYRANE Overview
Company Headquarters: Manchester, UK
Founded: 2006
Company Working: Oxyrane is a biopharmaceutical company involved in developing innovative enzyme replacement therapies for the treatment of lysosomal storage diseases. The company delivers human lysosomal enzymes that permit clinically useful enzyme uptake and localization using its glycoengineered yeast platform. The company operates in Belgium, Burlington, and Massachusetts.
Strategy
Oxyrane focuses on developing innovative technologies to deliver best-in-class solutions. It also aims at providing quality products and services to maintain a diversified business with a strong pipeline of new products.



